Blood Test Plus MRI May Better Predict New MS Lesions
Key Takeaway
A blood test combined with MRI scans identified two MS patterns, one linked to a higher chance of new lesions.
What They Found
Researchers combined MRI scans with a blood test that measures signs of nerve damage. They identified two MS patterns based on when blood test levels rose and changes appeared on scans. In one pattern, blood test levels rose early, and new lesions appeared sooner. In the other, parts of the brain shrank early, while blood test levels rose later. The first group had a higher risk of new lesions than the second group.
Who Should Care and Why
The study included people with relapsing-remitting MS and secondary progressive MS, plus a separate group of newly diagnosed people with MS. It focused on whether scans and a blood test could show different patterns of disease. The combined approach matched disability ratings more closely than scans alone. It also identified a group more likely to develop new lesions. These findings may help researchers study how MS changes over time.
Important Considerations
You should know this was a study of existing patient data, not a trial of a specific treatment. Researchers studied 189 people in the first group and 445 newly diagnosed people in a separate group. The abstract does not show that using this method to choose your treatment improves your health.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More
10/7/2026
A 3D-printed immune implant eased advanced MS-like disease in mice without broadly weakening immunit
Read More
10/6/2026
Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain : a journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.